The stock market performance of 4D Molecular Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $36.25 on 03/27/24, while the lowest price during the same time frame was $4.43, recorded on 01/23/25.
52-week price history of FDMT Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. 4D Molecular Therapeutics Inc’s current trading price is -83.64% away from its 52-week high, while its distance from the 52-week low is 33.86%. The stock’s price range for this period has remained between $4.43 and $36.25. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.1 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.88 million over the last three months.
Financial Performance and Market Capitalization
4D Molecular Therapeutics Inc (FDMT) has experienced a quarterly decline of -28.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 274.14M and boasts a workforce of 147 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.18, with a change in price of -9.32. Similarly, 4D Molecular Therapeutics Inc recorded 912,896 in trading volume during the last 100 days, posting a change of -61.11%.
FDMT Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for FDMT stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.04.
FDMT Stock Stochastic Average
As of today, the raw stochastic average of 4D Molecular Therapeutics Inc over the last 50 days is at 33.11%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 67.08%. Further, the company’s Stochastic %K and %D values for the last 20 days were 57.24% and 43.28%, respectively.
FDMT Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 6.46%.However, over the last six months, we can see a stronger performance of -65.50%. Over the last 30 days, the price of FDMT has fallen by 6.46%. And in the last five days, it has surged by 25.64%.
